Curis
CRIS
#10263
Rank
ยฃ8.42 M
Marketcap
ยฃ0.61
Share price
-8.58%
Change (1 day)
-71.92%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -ยฃ24.78 Million

According to Curis's latest financial reports the company's current earnings are ยฃ11.65 Million. In 2024 the company made an earning of -ยฃ32.19 Million, an increase over its 2023 earnings that were of -ยฃ34.16 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ24.78 Million-23.01%
2024 -ยฃ32.19 Million-5.77%
2023 -ยฃ34.16 Million-13.1%
2022 -ยฃ39.31 Million27.52%
2021 -ยฃ30.83 Million65.09%
2020 -ยฃ18.68 Million-9.1%
2019 -ยฃ20.54 Million-4.73%
2018 -ยฃ21.56 Million-41.95%
2017 -ยฃ37.14 Million-14.37%
2016 -ยฃ43.37 Million3.55%
2015 -ยฃ41.88 Million271.52%
2014 -ยฃ11.28 Million76.64%
2013 -ยฃ6.39 Million
2011 -ยฃ5.42 Million27.76%
2010 -ยฃ4.25 Million-43.87%
2009 -ยฃ7.56 Million-23.44%
2008 -ยฃ9.88 Million56.66%
2007 -ยฃ6.31 Million-16.71%
2006 -ยฃ7.57 Million-36.92%
2005 -ยฃ12 Million156.25%
2004 -ยฃ4.69 Million-37.24%
2003 -ยฃ7.46 Million-93.34%
2002 -ยฃ0.12 Billion86.79%
2001 -ยฃ59.96 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
ยฃ8.91 B-36,502.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ6.04 B-24,772.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-ยฃ46.57 Million 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
ยฃ0.65 B-2,782.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ0.2 Billion 687.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-ยฃ18.64 Million-23.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.12 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA